# Intravenous Immunoglobulin in Combination Therapy With Antibacterial Agents for SSI of the Lower Digestive Tract

> **NCT00511212** · NA · WITHDRAWN · sponsor: **Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group** · enrollment: 60 (estimated)

## Conditions studied

- Peritonitis
- Postoperative Complications

## Interventions

- **DRUG:** intravenous immunoglobulin

## Key facts

- **NCT ID:** NCT00511212
- **Lead sponsor:** Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2007-08
- **Primary completion:** —
- **Final completion:** 2009-06
- **Target enrollment:** 60 (ESTIMATED)
- **Why stopped:** No eligible patient.
- **Last updated:** 2011-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00511212

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00511212, "Intravenous Immunoglobulin in Combination Therapy With Antibacterial Agents for SSI of the Lower Digestive Tract". Retrieved via AI Analytics 2026-09-08 from https://api.ai-analytics.org/clinical/NCT00511212. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*